59:31

Anticoagulants in Older Adults

58:06

Ask the Experts

15:34

Veto do projeto que classifica o diabetes tipo 1 como deficiência - entenda

1:48:18

Updates in Evidence in the Management of Antiphospholipid Syndrome (APS)

25:07

Latest Advances in MPN Research 2024: Highlights from ASH 2023

1:00:57

Update on Andexanet Alfa for Reversal of FXa Inhibitors: Annexa-I Trial Webinar

1:03:18

Making Rounds: Medical Education Documentary Film

27:51

Direct-Acting Oral Anticoagulants (DOACs) | MOA , Indications, Adverse Reactions, Contraindications